ENTITY
SMARTSCORE: 3/5

Chinook Therapeutics (KDNY US)

2
Analysis
Health CareUnited States
Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company develops technology and precision medicines for severe chronic kidney diseases. Chinook Therapeutics serves patients worldwide.
more
21 Jun 2023 21:02

Consolidation Likely, But Little Reason to Be Bearish; Buys Within Biotech, Latin American Banks

$SPX is 1% above 4300-4325 which we anticipated would cap upside for 2023. Our view since May 30 (ETF Pathfinder) is we cannot be bearish if SPX is...

Logo
396 Views
Share
bearishS&P 500 INDEX
16 May 2023 21:38

SPX Forming Coiled Spring Between 4200 and 4050; 10Y/2Y Treasury Spread Suggests Recession Close

We continue believe that upside is limited with the $SPX testing the top-end of our anticipated 2023 trading range (4165-4200). On the off chance...

Logo
424 Views
Share
No more insights
x